Liposaccharide natural compounds consisting of a trisaccharide repeating unit (two heptose units and octulosonic acid) with oligosaccharide side chains and 3-hydroxytetradecanoic acid units (they are a major constituent of the cell walls of Gram-negative bacteria).
Chemical ID:
MESH:D008070
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Lipopolysaccharides results in increased secretion of PTGS2 protein]; 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Lipopolysaccharides results in increased secretion of PTGS2 protein]; [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [Dimethyl Sulfoxide co-treated with Resveratrol] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [IFNG protein co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein; [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of PTGS2 mRNA; [Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased expression of and results in increased activity of PTGS2 protein; [Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone; [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Lipopolysaccharides; [rofecoxib results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Lipopolysaccharides; alfacalcidol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; alfacalcidol promotes the reaction [Polyphenols inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; alfacalcidol promotes the reaction [Tea inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; allyl alcohol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; arsenic disulfide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Ascorbic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Estradiol inhibits the reaction [Lipopolysaccharides results in increased secretion of PTGS2 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; eugenosedin-A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of PTGS2 mRNA]; Indomethacin promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; MIR34A mRNA promotes the reaction [Sevoflurane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; MIR34A mRNA promotes the reaction [Sevoflurane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; nitroaspirin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; pimagedine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Polyphenols inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Polyphenols promotes the reaction [alfacalcidol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein]; Sevoflurane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Sevoflurane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; STAT1 inhibits the reaction [Sevoflurane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; STAT1 inhibits the reaction [Sevoflurane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; Tea inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Tea promotes the reaction [alfacalcidol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; tin protoporphyrin IX inhibits the reaction [Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; Trazodone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; triptolide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; triptolide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; wuzi yanzong analog inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; wuzi yanzong analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Yohimbine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
Lipopolysaccharides results in increased expression of PTGS2; Lipopolysaccharides results in increased expression of PTGS2 mRNA; Lipopolysaccharides results in increased expression of PTGS2 protein
Lipopolysaccharides results in increased expression of PTGS2; Lipopolysaccharides results in increased expression of PTGS2 mRNA; Lipopolysaccharides results in increased expression of PTGS2 protein
(4-(5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl)pyridin-2-yl)-(1-phenylethyl)amine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 1-Methyl-3-isobutylxanthine promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 1-phenyl-6,7-dihydroxy-isochroman inhibits the reaction [[Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; 1-phenyl-6,7-dihydroxy-isochroman inhibits the reaction [[Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane A2]; 1-phenyl-6,7-dihydroxy-isochroman inhibits the reaction [Lipopolysaccharides results in increased activity of PTGS2 protein]; 11-deoxyprostaglandin E1 promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid inhibits the reaction [[Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [Adenosine Triphosphate co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein; [Lipopolysaccharides co-treated with CAT protein] results in increased stability of PTGS2 protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PTGS2 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PTGS2 protein; [Lipopolysaccharides co-treated with Nicotine] results in increased expression of PTGS2 mRNA; [Lipopolysaccharides co-treated with Nicotine] results in increased expression of PTGS2 protein; [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA; [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein; [Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone; [Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane A2; [Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2; [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased abundance of Dinoprostone; [Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprost; [Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone; [Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone; [Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased secretion of prostaglandin F1; [Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of and results in increased secretion of Dinoprostone; [Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone; [peoniflorin co-treated with benzoylpaeoniflorin co-treated with Amygdalin] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA; [Tretinoin co-treated with Lipopolysaccharides co-treated with trichostatin A] results in decreased expression of PTGS2 protein; [Tretinoin co-treated with Lipopolysaccharides] results in decreased expression of PTGS2 protein; acetovanillone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; alloin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Amygdalin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Arachidonic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; BAY 11-7085 inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA]; BAY 11-7085 inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; Bee Venoms inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; benzoylpaeoniflorin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; Bresol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Bucladesine promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; butaprost promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; CBR1 protein modified form inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Cholera Toxin promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; cinnamaldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA]; cinnamaldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; citronellol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; cordycepin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; cordycepin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; CYBB mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Cycloheximide inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]; Dactinomycin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]; Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Dinoprostone inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; Dinoprostone promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; DUSP1 mutant form inhibits the reaction [trichostatin A inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]]; DUSP1 mutant form inhibits the reaction [trichostatin A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; ELAVL1 protein promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; entinostat inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; eupafolin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; eupafolin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Fatty Acids, Unsaturated inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone]; fluridone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; fluridone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; geraniol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; guizhi-fuling inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; honokiol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Ketoprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone]; Levamisole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Levamisole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein; manoalide inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; manoalide inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]; Masoprocol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Melitten inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; NCF1 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Particulate Matter promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Particulate Matter promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; peoniflorin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; peoniflorin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Plant Oils inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Quercetin promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [[Adenosine Triphosphate co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of PTGS2 protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprost]; Resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone]; Resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of and results in increased secretion of Dinoprostone]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; scalaradial inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; scalaradial inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]; Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; SIRT1 protein inhibits the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of PTGS2 mRNA]; SIRT1 protein inhibits the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of PTGS2 protein]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprost]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone]]; tanshinone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; TLR4 protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; TLR4 protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; TLR4 protein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; trichostatin A inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; trichostatin A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; trichostatin A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; U 0126 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Vehicle Emissions promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Vehicle Emissions promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]]; 1-Butanol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 1-Butanol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 12-dehydrogingerdione inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 15-deoxyprostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 15-deoxyprostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 17-hydroxyjolkinolide B inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 17-hydroxyjolkinolide B inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 2,2'-biphenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 2-chloro-4'-methoxychalcone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 3,3'-diindolylmethane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 3,4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 3,4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 3-(4-chlorophenylselanyl)-1-methyl-1H-indole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 4,8-bis(4-hydroxy-3-methoxyphenyl)-3,7-dioxabicyclo(3.3.0)octane-2,6-dione inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; 4-((2'-O-acetylrhamnosyloxy)benzyl)isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 4-((2'-O-acetylrhamnosyloxy)benzyl)isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]; 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; 5-dimethylamiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [4,4'-dihydroxybiphenyl co-treated with Lipopolysaccharides] results in increased expression of PTGS2; [Drugs, Chinese Herbal co-treated with niuhuang] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; [Dust co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA; [Ethanol co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein; [ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate co-treated with cordycepin] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; [ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate co-treated with cordycepin] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA; [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein; [KT 5720 co-treated with Dinoprostone] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; [Lipopolysaccharides co-treated with benzyloxycarbonyl-valyl-alanyl-aspartic acid] results in increased expression of PTGS2 protein; [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PTGS2 protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein; [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased abundance of Dinoprostone; [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased metabolism of Arachidonic Acid; [Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone; [Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone; [Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone; [Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased secretion of Dinoprostone; [Manganese co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA; [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA; acetovanillone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; aciculatin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; aciculatin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; AHR protein affects the reaction [[Dust co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA]; AHR protein affects the reaction [[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA]; AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; allylpyrocatechol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; alpha-viniferin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; alpha-viniferin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; alternaramide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Anti-Inflammatory Agents inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Anti-Inflammatory Agents inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; ANXA1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; ANXA1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; arctigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; arctiin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Arsenic Trioxide promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; asarone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; asarone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; aureusidin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; aureusidin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; balanophonin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Bee Venoms inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Bee Venoms inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; beta-amyrin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; beta-hydroxyisovalerylshikonin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; beta-hydroxyisovalerylshikonin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; beta-ionone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; beta-ionone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; boric acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Bucladesine promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; caffeic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Caffeine inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]; Caffeine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Caffeine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Capsaicin inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]; Capsaicin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Capsaicin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; capsazepine inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]; capsazepine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; capsazepine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Carthamus yellow inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Carthamus yellow inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; catalpol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; CD14 protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Celecoxib results in decreased susceptibility to [Lipopolysaccharides results in increased expression of PTGS2 protein]; chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; ciglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; ciglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; cirsimarin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; cirsimarin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; citronellol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; citronellol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; copper protoporphyrin IX inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; cordycepin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; cordycepin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; creosol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; dehydrodiisoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; dehydrodiisoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; dehydrodiisoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; delphinidin 3-O-glucopyranoside inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Dextromethorphan inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; diallyl disulfide inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein]; diallyl trisulfide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; diaoxinxuekang inhibits the reaction [Lipopolysaccharides results in decreased expression of PTGS2 mRNA]; diaoxinxuekang inhibits the reaction [Lipopolysaccharides results in decreased expression of PTGS2 protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; dihydrotanshinone I inhibits the reaction [[Lipopolysaccharides co-treated with benzyloxycarbonyl-valyl-alanyl-aspartic acid] results in increased expression of PTGS2 protein]; dihydrotanshinone I inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Dinoprostone inhibits the reaction [copper protoporphyrin IX inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; Dinoprostone promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Dizocilpine Maleate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; dorsomorphin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Drugs, Chinese Herbal inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; DUSP1 gene mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; DUSP1 mRNA affects the reaction [Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; epimuqubilin A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; epimuqubilin A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; epoxy resin AH-26 promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; eriodictyol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate promotes the reaction [diallyl trisulfide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; ethylisopropylamiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased abundance of Dinoprostone]; Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased metabolism of Arachidonic Acid]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; eupafolin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; FAAH protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; FAAH protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; ferulic acid analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; flavokawain A inhibits the reaction [Lipopolysaccharides promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; flavone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; flavone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone]; formononetin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; fucoxanthin analog affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; fucoxanthin analog affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; Genistein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Genistein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; genistin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; geraniol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; geraniol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; ginsenoside Re inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Glucosamine inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased secretion of Dinoprostone]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; glycyrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Guaiacol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; helenalin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; hinokiflavone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; homoeriodictyol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; homoeriodictyol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; honokiol analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; icariin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; icariin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Indirubin E804 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Indirubin E804 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Indomethacin inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA]; Indomethacin inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein]; Indomethacin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; isolariciresinol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; isostevic acid metabolite inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Isothiocyanates inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Isothiocyanates inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; ITGAM protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; kaempferol 7-O-glucoside inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; kaempferol 7-O-glucoside inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; KT 5720 affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Lipopolysaccharides promotes the reaction [epoxy resin AH-26 results in increased expression of PTGS2 mRNA]; Lipopolysaccharides promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]; Lipopolysaccharides promotes the reaction [Sealapex results in increased expression of PTGS2 mRNA]; Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein; luteolin-7-O-glucuronide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; LY 311727 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; LY 311727 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; lycorine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein]; matairesinol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Melitten inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Melitten inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; monotropein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; monotropein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; morroniside inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; morroniside inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; MST1R gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; narciclasine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; narciclasine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; naringin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; nimesulide inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA]; nimesulide inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein]; nimesulide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; nonylphenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Organoselenium Compounds results in decreased susceptibility to [Lipopolysaccharides results in increased expression of PTGS2 protein]; Particulate Matter analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Particulate Matter analog promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; pelargonidin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; PF 3845 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; PF 3845 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; phlorofucofuroeckol A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; pinoresinol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Piroxicam inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Plant Extracts inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Plant Oils inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Plant Oils inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; platycodin D inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; platycodin D inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Polymyxin B inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Polysaccharides inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; prolinedithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Propranolol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; prosapogenin D methyl ester inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; prosapogenin D methyl ester inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; prostaglandin A1 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of PTGS2 protein]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; protoporphyrin IX inhibits the reaction [Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; pyrazolanthrone inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; pyrazolanthrone promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; quercetin pentaacetate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; resolvin D1 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; resolvin D2 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Resveratrol analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; S Ht31 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; S-allylcysteine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PTGS2 protein]; salvianolic acid A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; salvin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; scutellarein tetramethyl ether inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; scutellarein tetramethyl ether inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Scutellaria baicalensis extract inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Sealapex promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Selenium deficiency promotes the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Selenium deficiency promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; septilin inhibits the reaction [Lipopolysaccharides results in increased activity of PTGS2 protein]; sesamol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; sodium pentaborate analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Sodium Selenite inhibits the reaction [pyrazolanthrone promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; sophocarpine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; sophoricoside inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; sophoricoside inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; soyasaponin I inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Stigmasterol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Stigmasterol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; syringaresinol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Tamoxifen inhibits the reaction [Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; taxifolin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; terameprocol affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; tetrahydrocurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Thalidomide analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Thiourea results in decreased susceptibility to [Lipopolysaccharides results in increased expression of PTGS2 protein]; TLR4 gene mutant form affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; TLR4 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; TLR4 protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; tricyclodecane-9-yl-xanthogenate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; tricyclodecane-9-yl-xanthogenate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; triptolide inhibits the reaction [Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; Triterpenes inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Triterpenes inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; vanillin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Vaticanol B inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Vehicle Emissions analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Vehicle Emissions analog promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; withaferin A inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; withaferin A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; wogonin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; wogonin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein]; Wortmannin inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; Wortmannin inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; zinc protoporphyrin inhibits the reaction [sesamol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; zinc protoporphyrin promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]